SCHEMBL4459778

SCHEMBL4459778

Cc1nc(N2CCOCC2)ccc1-c1ccc(NC(=O)Nc2cc(C(C)(C)C)ccc2-n2ccnc2)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.44
IDH2 P48735 1/20 0.44
ALDH1A1 P00352 3/20 0.42
BRAF P15056 4/20 0.41
LMNA P02545 1/20 0.41
RAF1 P04049 4/20 0.40
KDM4E B2RXH2 4/20 0.40
GSK3A P49840 3/20 0.40
CLK2 P49760 1/20 0.40
GSK3B P49841 1/20 0.40
CSNK2A1 P68400 1/20 0.40
STK3 Q13188 1/20 0.40
HIPK4 Q8NE63 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
KMT2A Q03164 1/20 0.40
ABL1 P00519 2/20 0.39
LYN P07948 2/20 0.39
MAPK9 P45984 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070212 0.82 MAPK14 (0.49) MAPK14ALDH1A1BRAFRAF1KDM4E
SCHEMBL4091644 0.79 MAPK14 (0.72) MAPK14IDH2ALDH1A1BRAFLMNA
SCHEMBL27578812 0.79 MAPK14 (0.44) MAPK14ALDH1A1BRAFRAF1KDM4E
SCHEMBL7069581 0.79 BRAF (0.53) MAPK14BRAFRAF1GSK3AABL1
SCHEMBL4464429 0.77 PIK3CA (0.52) ALDH1A1KDM4EGSK3ACLK2GSK3B
SCHEMBL4464303 0.77 MAPK14 (0.42) MAPK14BRAFRAF1KDM4EGSK3A
SCHEMBL27559838 0.77 MAPK14 (0.54) MAPK14ALDH1A1BRAFLMNARAF1
SCHEMBL4453272 0.76 BRAF (0.48) MAPK14BRAFRAF1GSK3AABL1
SCHEMBL7189256 0.75 RAF1 (0.54) IDH2BRAFRAF1KDM4EGSK3A
SCHEMBL27559804 0.75 MAPK14 (0.50) MAPK14BRAFRAF1KDM4EGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2116245-A2 EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders Boehringer Ingelheim International GmbH (DE) 2009-11-11 EP disclosed